These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32832402)

  • 1. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States.
    Gadiparthi C; Spatz M; Greenberg S; Iqbal U; Kanna S; Satapathy SK; Broder A; Ahmed A
    J Clin Transl Hepatol; 2020 Jun; 8(2):215-221. PubMed ID: 32832402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.
    Liu A; Galoosian A; Kaswala D; Li AA; Gadiparthi C; Cholankeril G; Kim D; Ahmed A
    J Clin Transl Hepatol; 2018 Dec; 6(4):420-424. PubMed ID: 30637220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Patel YA; Berg CL; Moylan CA
    Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
    Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
    Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis recurrence after liver transplant.
    Taneja S; Roy A
    Transl Gastroenterol Hepatol; 2020; 5():24. PubMed ID: 32258528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
    Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
    Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.
    Ahmed A; Wong RJ; Harrison SA
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2062-70. PubMed ID: 26226097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.
    Iqbal U; Perumpail BJ; Akhtar D; Kim D; Ahmed A
    Medicines (Basel); 2019 Mar; 6(1):. PubMed ID: 30889791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
    Khullar V; Dolganiuc A; Firpi RJ
    World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Steatohepatitis: A Review.
    Sheka AC; Adeyi O; Thompson J; Hameed B; Crawford PA; Ikramuddin S
    JAMA; 2020 Mar; 323(12):1175-1183. PubMed ID: 32207804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease.
    Kalogirou MS; Giouleme O
    World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis After Liver Transplantation.
    Cotter TG; Charlton M
    Liver Transpl; 2020 Jan; 26(1):141-159. PubMed ID: 31610081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times.
    Gitto S; Marra F; De Maria N; Bihl F; Villa E; Andreone P; Burra P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):173-178. PubMed ID: 30791778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.
    Ching-Yeung Yu B; Kwok D; Wong VW
    J Clin Exp Hepatol; 2019; 9(4):491-496. PubMed ID: 31516265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.